Skip to main content
SpringerLink
Log in
SpringerLink
Log in

Analysis of Growth Regulatory Pathways in Human Neuro-Oncology

  • Conference paper
Molecular Diagnostics of Cancer

  • 54 Accesses

Abstract

Considering the therapies which are available today for human gliomas, the most promising new developments are to be expected from advances in the understanding of glial cell biology together with the technical capacity to manipulate cells by biochemical or molecular biological means. Herein, the exploration of growth factor pathways that may be deregulated has provided new understanding of the disease as well as therapeutic perspectives. The concomitant expression of growth factor receptors and secretion of growth factors resulting in autocrine self-stimulation of cells, which is frequently found in oncology [1, 14], is also present in glial tumors and will be presented from the neuro-oncological aspect.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Aaronson SA (1991) Growth factors and cancer. Science 254:1146–1153

    Article  PubMed  CAS  Google Scholar 

  2. Bigner SH, Burger PC, Wong AJ, Werner MH, Hamilton SR, Muhlbaier LH, Vogelstein B, Bigner DD (1988) Gene amplification in malignant human gliomas: clinical and histopathological aspects. J Neuropath Exp Neurol 47: 191–205

    Article  PubMed  CAS  Google Scholar 

  3. Bögler O, Wren D, Barnett SC, Land H, Noble M (1990) Cooperation between two growth factors promotes extended self renewal and inhibits differentiation of oligodendrocyte-type-2 astrocyte (02A) progenitor cells. Proc Natl Acad Sci USA 87:6368–6372

    Article  PubMed  Google Scholar 

  4. Burger P, Heinz ER, Shibata T, Kleihues P (1988) Topographic anatomy and CT correlations in the untreated glioblastoma multiforme. J Neurosurg 68: 698–704

    Article  PubMed  CAS  Google Scholar 

  5. Chellappan SP, Hiebert S, Mudryi M, Horowitz JM, Nevins JR (1991) The E2F transcription factor is a cellular target for the RB protein. Cell 65:1053–1061

    Article  PubMed  CAS  Google Scholar 

  6. Deinhardt F (1980) Biology of primate retroviruses. In: Klein G (ed) Viral oncology. Raven, New York, pp 357–398

    Google Scholar 

  7. Erickson CA, Turley EA (1987) The effects of epidermal growth factor on neural crest cells in tissue culture. Exp Cell Res 169:267–279

    Article  PubMed  CAS  Google Scholar 

  8. Friend SH, Horowitz JM, Gerber MR, Wang XF, Bogenmann E, Li FP, Weinberg RA (1987) Deletions of a DNA sequence in retinoblastomas and mesenchymal tumors: organization of the sequence and its encoded protein. Proc Natl Acad Sci USA 84:9059–9063

    Article  PubMed  CAS  Google Scholar 

  9. Fults D, Tippets RH, Thomas GA, Nakamura Y, White R (1989) Loss of heterozygosity for loci on chromosome 17p in human malignant astrocytoma. Cancer Res 49:6572–6577

    PubMed  CAS  Google Scholar 

  10. Gross JL, Morrison RS, Eidsvoog K, Herblin WF, Kornblith PL, Dexter DL (1990) Basic fibroblast growth factor: a potential autocrine regulator of human glioma cell growth. J Neurosci Res 27:689–696

    Article  PubMed  CAS  Google Scholar 

  11. Haley JD, Hsuan JJ, Waterfield MD (1989) Analysis of mammalian fibroblast transformation by normal and mutated human EGF receptors. Oncogene 4: 273–283

    PubMed  CAS  Google Scholar 

  12. Hall WA, Fodstad O (1992) Immunotoxins and the central nervous system. J Neurosurg 76:1 — 12

    Article  PubMed  CAS  Google Scholar 

  13. Haluska FG, Tsujimoto Y, Croce CM (1987) Oncogene activation by chromosome translocation in human malignancy. Annu Rev Genet 21:321–345

    Article  PubMed  CAS  Google Scholar 

  14. Heldin CH, Betzholz C, Claesson-Welsh L, Westermark B (1987) Subversion of growth regulatory pathways in malignant transformation. Biochim Biophys Acta 907:219–244

    PubMed  CAS  Google Scholar 

  15. Henn W, Blin N, Zang KD (1986) Polysomy of chromosome 7 is correlated with overexpression of the erbB oncogene in human glioblastoma cell lines. Hum Genet 74:104–106

    Article  PubMed  CAS  Google Scholar 

  16. Huang SS, Huang JS (1988) Turnover of the platelet-derived growth factor receptor in transformed cells and reversal by suramin. J Biol Chem 263: 12608–12618

    PubMed  CAS  Google Scholar 

  17. Humphrey PA, Wong AJ, Gangarosa LM, Archer GE, Lund-Johansen M, Bjerkvig R, Laerum OD, Friedman HS, Bigner DD (1991) Deletion-mutant epidermal growth factor receptors in human glioblastomas. IXth international conference on brain tumor research and therapy, (abstr) ASILOMAR, Oktolar 1991

    Google Scholar 

  18. James CD, Carlbom E, Nordenskjold M, Collins P, Cavenee WK (1989) Mitotic recombination of chromosome 17 in astrocytomas. Proc Natl Acad Sci USA 86:2858–2862

    Article  PubMed  CAS  Google Scholar 

  19. James CD, He J, Carlbom E, Nordenskjold M, Cavanee WK, Collins VP (1991) Chromosome deletion mapping reveals interferon a and interferon (3–1 gene deletions in human glial tumors. Cancer Res 51:1684–1688

    PubMed  CAS  Google Scholar 

  20. Kopp R, Pfeiffer A (1990) Suramin alters phosphoinositide synthesis and inhibits growth factor receptor binding in HT-29 cells. Cancer Res 50:6490–6496

    PubMed  CAS  Google Scholar 

  21. Lee WH, Shew JW, Hong FD, Sery TW, Donoso LA, Young LJ, Bookstein R, Lee EYHP (1987) The retinoblastoma susceptablity gene encodes a nuclear phosphoprotein associated with DNA-binding activity. Nature 329:642–645

    Article  PubMed  CAS  Google Scholar 

  22. Libermann TA, Nusbaum HR, Razon N, Kris R, Lax I, Soreq H, Whittle N, Waterfield MD, Ullrich A, Schlessinger J (1985) Amplification, enhanced expression and possible rearrangement of EGF-receptor gene in primary human brain tumors of glial origin. Nature 313:144–147

    Article  PubMed  CAS  Google Scholar 

  23. Lund-Johansen M, Bjerkvig R, Humphrey PA, Bigner SH, Bigner DD, Laerum O-D (1990) Effect of epidermal growth factor on glioma cell growth, migration and invasion in vitro. Cancer Res 50:6039–6044

    PubMed  CAS  Google Scholar 

  24. Mercer WE, Shields MT, Amin M, Sauve GJ, Apella E, Romano JW, Ullrich SJ (1990)Negative growth regulation in a glioblastoma tumor cell line that conditionally expresses human wild-type p53. Proc Natl Acad Sci USA 87: 6166–6170

    Article  PubMed  CAS  Google Scholar 

  25. Mikkelsen T, Cairncross G, Cavanee WK (1991) Genetics of the malignant progression of astrocytoma. J Cell Biochem 46:3–8

    Article  PubMed  CAS  Google Scholar 

  26. Morrison RS (1991) Suppression of basic fibroblast growth factor expression by antisense oligodeoxynucleotides inhibits the growth of transformed human astrocytes. J Biol Chem 266:728–734

    PubMed  CAS  Google Scholar 

  27. Nister M, Hammacher A, Mellstrom K, Siegbahn A, Ronnstrand L, Westermark B, Heldin CH (1988) A glioma-derived PDGF A chain homodimer has different functional activities from a PDGF AB hetrodimer purified from human platelets. Cell 52:791–799

    Article  PubMed  CAS  Google Scholar 

  28. Nister M, Libermann TA, Betsholz C, Pettersson M, Claesson-Welsh L, Heldin CH, Schlessinger J, Westermark B (1988) Expression of messenger RNAs for platelet-derived growth factors and transforming growth factor a and their receptors in human malignant glioma cell lines. Cancer Res 48:3910–3918

    PubMed  CAS  Google Scholar 

  29. Ohgaki H, Eibl RH, Wiestler OD, Yasargil G, Newcomb EW, Kleihues P (1991) p53 mutations in non-astrocytic human brain tumors. Cancer Res 51:6202–6205

    PubMed  CAS  Google Scholar 

  30. Olivier S, Formento P, Fischel JL, Etienne MC, Milano G (1990) Epidermal growth factor receptor expression and suramin cytotoxicity in vitro. Eur J Cancer 26:876–871

    Article  Google Scholar 

  31. Raff MC (1989) Glial cell diversification in the rat optic nerve. Science 243:1450–1455

    Article  PubMed  CAS  Google Scholar 

  32. Raff MD, Lillien LE, Richardson WD, Burne JF, Noble MD (1988) Platelet-derived growth factor from astrocytes drives the clock that times oligodendrocyte development in culture. Nature 333:562–565

    Article  PubMed  CAS  Google Scholar 

  33. Schlegel U, Moots PL, Rosenblum MK, Thaler HT, Furneaux HM (1990) Expression of transforming growth factor alpha in human gliomas. Oncogene 5:1839–1849

    PubMed  CAS  Google Scholar 

  34. Simpson Dl, Morrison R, de Vellis J, Herschman HR (1982) Epidermal growth factor binding and mitogenic activity on purified populations of cells from the central nervous system. J Neurosci Res 8:453–462

    Article  PubMed  CAS  Google Scholar 

  35. Sjolund M, Thyberg J (1989) Suramin inhibits binding and degradation of platelet-derived growth factor in arterial smooth muscle cells but does not interfere with autocrine stimulation of DNA synthesis. Cell Tissue Res 256: 35–43

    Article  PubMed  CAS  Google Scholar 

  36. Stenman G, Rorsman F, Betsholtz C (1988) Sublocalization of the human PDGF A-chain gene to chromosome 7, band qll.23, by in situ hybridization. Exp Cell Res 178:180–184

    Article  PubMed  CAS  Google Scholar 

  37. Stern DF, Hare DL, Cecchini MA, Weinberg RA (1987) Construction of a novel oncogene based on synthetic sequences encoding epidermal growth factor. Science 235:321–324

    Article  PubMed  CAS  Google Scholar 

  38. Sugawa N, Ekstrand AJ, James CD, Collins VP (1990) Identical splicing of aberrant epidermal growth factor transcripts from amplified rearranged genes in human glioblastomas. Proc Natl Acad Sci USA 87:8602–8606

    Article  PubMed  CAS  Google Scholar 

  39. Takahashi JA, Mori H, Fukamoto M, Igarashi K, Jaye M, Oda Y, Kikuchi H, Hatanaka M (1990) Gene expression of fibroblast growth factors in human gliomas and meningiomas: demonstration of cellular source of basic fibroblastgrowth factor mRNA and peptide in tumor tissues. Proc Natl Acad Sci USA 87:5710–5714

    Article  PubMed  CAS  Google Scholar 

  40. Torp SH, Heiseth E, Dalen A, Unsgaard G (1991) Epidermal growth factor expression in human gliomas. Cancer Immunol Immunother 33:61–64

    Article  PubMed  CAS  Google Scholar 

  41. Venter DJ, Bevan KL, Ludwig RL, Riley TEW, Jat PS, Thomas DGT, Noble M (1991) Retinoblastoma gene deletions in human glioblastomas. Oncogene 6:445–448

    PubMed  CAS  Google Scholar 

  42. Weber W, Gill GN, Spiess J (1984) Production of an epidermal growth factor receptor related protein. Science 224:294–297

    Article  PubMed  CAS  Google Scholar 

  43. Weinberg RA (1991) Tumor suppressor genes. Science 254:1138–1146

    Article  PubMed  CAS  Google Scholar 

  44. Westermark B, Magnusson A, Heldin CH (1982) Effect of epidermal growth factor on membrane motility and cell locomotion in cultures of human clonal glioma cells. J Neurosci Res 8:491–507

    Article  PubMed  CAS  Google Scholar 

  45. Westphal M, Uhlig H, Rohde E, Herrmann HD (1988) EGF-Rezeptoren in menschlichen Gliomen und ihre biologischen Implikationen. In: Bamberg M, Sack H (eds) Therapie primärer Hirntumoren. Zuckschwerdt, Munich, pp 17–21

    Google Scholar 

  46. Westphal M, Brunken M, Rohde E, Herrmann HD (1988) Growth factors in cultured human glioma cells: differential effects of FGF, EGF and PGDF. Cancer Lett 38:283–296

    Article  PubMed  CAS  Google Scholar 

  47. Westphal M, Nausch H, Herrmann HD (1989) Cyst fluids of malignant human brain tumors contain substances that stimulate the growth of cultured human gliomas of various histological type. Neurosurgery 25:196–201

    Article  PubMed  CAS  Google Scholar 

  48. Westphal M, Herrmann HD (1989) Growth factor biology and oncogene activation in human gliomas and their implications for specific therapeutic concepts. Neurosurgery 25:681–694

    Article  PubMed  CAS  Google Scholar 

  49. Westphal M, Ackermann E, Hoppe J, Herrmann HD (1991) Receptors for platelet derived growth factor in human glioma cell lines and influence of suramin on cell proliferation. J Neurooncol 11:207–213

    Article  PubMed  CAS  Google Scholar 

  50. Westphal M, Nitschke M, Nausch H, Herrmann HD (1992) Cell lines derived from human gliomas activate multiple autocrine pathways simultaneously. Neurosurgery (submitted)

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Abteilung für Neurochirurgie, Labor für Hirntumorbiologie, Universitätskrankenhaus Eppendorf, Martinistraße 52, W-2000, Hamburg 20, Germany

    M. Westphal, W. Hamel, L. Anker & H.-D. Herrmann

Authors
  1. M. Westphal
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. W. Hamel
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. L. Anker
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. H.-D. Herrmann
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Abteilung für Klinische Chemie, Medizinische Klinik, Universitäts-Krankenhaus Eppendorf, Martinistraße 52, W-2000, Hamburg 20, Germany

    Christoph Wagener

  2. Diagnostische Forschung E. Merck, Frankfurter Straße 250, W-6100, Darmstadt, Germany

    Siegfried Neumann

Rights and permissions

Reprints and permissions

Copyright information

© 1993 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Westphal, M., Hamel, W., Anker, L., Herrmann, HD. (1993). Analysis of Growth Regulatory Pathways in Human Neuro-Oncology. In: Wagener, C., Neumann, S. (eds) Molecular Diagnostics of Cancer. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-77521-5_13

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-77521-5_13

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-55476-9

  • Online ISBN: 978-3-642-77521-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation